55 related articles for article (PubMed ID: 14612537)
1. Characterization of a novel cyclin-dependent kinase 1 inhibitor, BMI-1026.
Seong YS; Min C; Li L; Yang JY; Kim SY; Cao X; Kim K; Yuspa SH; Chung HH; Lee KS
Cancer Res; 2003 Nov; 63(21):7384-91. PubMed ID: 14612537
[TBL] [Abstract][Full Text] [Related]
2. The identification and characterization of the marine natural product scytonemin as a novel antiproliferative pharmacophore.
Stevenson CS; Capper EA; Roshak AK; Marquez B; Eichman C; Jackson JR; Mattern M; Gerwick WH; Jacobs RS; Marshall LA
J Pharmacol Exp Ther; 2002 Nov; 303(2):858-66. PubMed ID: 12388673
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of polo-like kinase 1 leads to the suppression of osteosarcoma cell growth in vitro and in vivo.
Liu X; Choy E; Harmon D; Yang S; Yang C; Mankin H; Hornicek FJ; Duan Z
Anticancer Drugs; 2011 Jun; 22(5):444-53. PubMed ID: 21399492
[TBL] [Abstract][Full Text] [Related]
4. Induction of mitotic arrest and apoptosis by a novel synthetic quinolone analogue, CWC-8, via intrinsic and extrinsic apoptotic pathways in human osteogenic sarcoma U-2 OS cells.
Chang YH; Yang JS; Kuo SC; Chung JG
Anticancer Res; 2009 Aug; 29(8):3139-48. PubMed ID: 19661327
[TBL] [Abstract][Full Text] [Related]
5. Alsterpaullone, a novel cyclin-dependent kinase inhibitor, induces apoptosis by activation of caspase-9 due to perturbation in mitochondrial membrane potential.
Lahusen T; De Siervi A; Kunick C; Senderowicz AM
Mol Carcinog; 2003 Apr; 36(4):183-94. PubMed ID: 12669310
[TBL] [Abstract][Full Text] [Related]
6. The cell cycle checkpoint kinase Chk2 is a negative regulator of mitotic catastrophe.
Castedo M; Perfettini JL; Roumier T; Yakushijin K; Horne D; Medema R; Kroemer G
Oncogene; 2004 May; 23(25):4353-61. PubMed ID: 15048074
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
Arita Y; Buffolino P; Coppock DL
Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
[TBL] [Abstract][Full Text] [Related]
8. Perifosine, a novel alkylphospholipid, induces p21(WAF1) expression in squamous carcinoma cells through a p53-independent pathway, leading to loss in cyclin-dependent kinase activity and cell cycle arrest.
Patel V; Lahusen T; Sy T; Sausville EA; Gutkind JS; Senderowicz AM
Cancer Res; 2002 Mar; 62(5):1401-9. PubMed ID: 11888912
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells.
Marko D; Schätzle S; Friedel A; Genzlinger A; Zankl H; Meijer L; Eisenbrand G
Br J Cancer; 2001 Jan; 84(2):283-9. PubMed ID: 11161389
[TBL] [Abstract][Full Text] [Related]
10. Targeted therapy of human osteosarcoma with 17AAG or rapamycin: characterization of induced apoptosis and inhibition of mTOR and Akt/MAPK/Wnt pathways.
Gazitt Y; Kolaparthi V; Moncada K; Thomas C; Freeman J
Int J Oncol; 2009 Feb; 34(2):551-61. PubMed ID: 19148492
[TBL] [Abstract][Full Text] [Related]
11. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells.
Agarwal C; Singh RP; Dhanalakshmi S; Tyagi AK; Tecklenburg M; Sclafani RA; Agarwal R
Oncogene; 2003 Nov; 22(51):8271-82. PubMed ID: 14614451
[TBL] [Abstract][Full Text] [Related]
12. p42/p44 MAPKs are intracellular targets of the CDK inhibitor purvalanol.
Knockaert M; Lenormand P; Gray N; Schultz P; Pouysségur J; Meijer L
Oncogene; 2002 Sep; 21(42):6413-24. PubMed ID: 12226745
[TBL] [Abstract][Full Text] [Related]
13. MJ-29 inhibits tubulin polymerization, induces mitotic arrest, and triggers apoptosis via cyclin-dependent kinase 1-mediated Bcl-2 phosphorylation in human leukemia U937 cells.
Yang JS; Hour MJ; Huang WW; Lin KL; Kuo SC; Chung JG
J Pharmacol Exp Ther; 2010 Aug; 334(2):477-88. PubMed ID: 20463006
[TBL] [Abstract][Full Text] [Related]
14. The novel synthesized 2-(3-(methylamino)phenyl)-6-(pyrrolidin-1-yl)quinolin-4-one (Smh-3) compound induces G2/M phase arrest and mitochondrial-dependent apoptotic cell death through inhibition of CDK1 and AKT activity in HL-60 human leukemia cells.
Huang SM; Yang JS; Tsai SC; Chen MH; Hsu MH; Lin HY; Chou LC; Chinag JH; Lee KH; Huang LJ; Kuo SC
Int J Oncol; 2011 May; 38(5):1357-64. PubMed ID: 21344160
[TBL] [Abstract][Full Text] [Related]
15. BI 2536-mediated PLK1 inhibition suppresses HOS and MG-63 osteosarcoma cell line growth and clonogenicity.
Morales AG; Brassesco MS; Pezuk JA; Oliveira JC; Montaldi AP; Sakamoto-Hojo ET; Scrideli CA; Tone LG
Anticancer Drugs; 2011 Nov; 22(10):995-1001. PubMed ID: 21822121
[TBL] [Abstract][Full Text] [Related]
16. Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1.
Vassilev LT; Tovar C; Chen S; Knezevic D; Zhao X; Sun H; Heimbrook DC; Chen L
Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10660-5. PubMed ID: 16818887
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cyclin-dependent kinase 1 induces cytokinesis without chromosome segregation in an ECT2 and MgcRacGAP-dependent manner.
Niiya F; Xie X; Lee KS; Inoue H; Miki T
J Biol Chem; 2005 Oct; 280(43):36502-9. PubMed ID: 16118207
[TBL] [Abstract][Full Text] [Related]
18. Dinaciclib Induces Anaphase Catastrophe in Lung Cancer Cells via Inhibition of Cyclin-Dependent Kinases 1 and 2.
Danilov AV; Hu S; Orr B; Godek K; Mustachio LM; Sekula D; Liu X; Kawakami M; Johnson FM; Compton DA; Freemantle SJ; Dmitrovsky E
Mol Cancer Ther; 2016 Nov; 15(11):2758-2766. PubMed ID: 27550941
[TBL] [Abstract][Full Text] [Related]
19. Cyclin dependent kinase 1 inhibitors: a review of recent progress.
Wang Q; Su L; Liu N; Zhang L; Xu W; Fang H
Curr Med Chem; 2011; 18(13):2025-43. PubMed ID: 21517772
[TBL] [Abstract][Full Text] [Related]
20. The cellular phenotype of AZ703, a novel selective imidazo[1,2-a]pyridine cyclin-dependent kinase inhibitor.
Byth KF; Geh C; Forder CL; Oakes SE; Thomas AP
Mol Cancer Ther; 2006 Mar; 5(3):655-64. PubMed ID: 16546980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
